↓ Skip to main content

Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine

Overview of attention for article published in Experimental Hematology & Oncology, December 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#12 of 133)
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

blogs
1 blog
twitter
6 tweeters

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
131 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine
Published in
Experimental Hematology & Oncology, December 2018
DOI 10.1186/s40164-018-0122-9
Pubmed ID
Authors

Hanxiao Xu, Ying Jiao, Shuang Qin, Weiheng Zhao, Qian Chu, Kongming Wu

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 131 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 25 19%
Student > Ph. D. Student 22 17%
Student > Master 18 14%
Researcher 15 11%
Student > Postgraduate 7 5%
Other 15 11%
Unknown 29 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 37 28%
Agricultural and Biological Sciences 12 9%
Medicine and Dentistry 9 7%
Neuroscience 8 6%
Engineering 7 5%
Other 26 20%
Unknown 32 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2020.
All research outputs
#1,823,892
of 14,983,162 outputs
Outputs from Experimental Hematology & Oncology
#12
of 133 outputs
Outputs of similar age
#69,757
of 379,928 outputs
Outputs of similar age from Experimental Hematology & Oncology
#7
of 22 outputs
Altmetric has tracked 14,983,162 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 133 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 379,928 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.